Earnings per share for the last twelve months: Nexalin Technology (NXL)

Official company branding of Nexalin (NXL)

Nexalin Technology, Inc. (NXL) is implementing a unique neurostimulation ecosystem, creating a high level of clinic dependency on its protocols. The company's TTM earnings per share allow investors to filter out market noise and determine the asset's real value, with the metric currently standing at -13.60. Growth is driven by new licenses for anxiety treatment, while the diversification of assembly within the US guarantees the stability of component supplies.

NXL (Nexalin Technology, Inc.) Net earnings per share for the last four quarters history from 04/28/2023 to 11/15/2026

Analytical breakdowns for nexalin.com (NXL)

- stock price and consensus target price:
Stock Price Nexalin Technology, Inc.|NXL - Analyst Consensus Forecast
- company stock exchange capitalization indicators:
Market Value Nexalin|NXL - Total Company Value
- shareholders' equity book value data:
Book Value per Share Nexalin Technology|NXL - Book Valuation of Business|Market Value to Book Value Ratio nexalin.com|NXL - Total Business Assets
- company total debt and liquidity indicators:
Total Debt to Equity Ratio Nexalin Technology, Inc.|NXL - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio Nexalin|NXL - Company Cumulative Indebtedness|Debts to Book Capitalization Nexalin Technology, Inc.|NXL - Long-Term Debt|Company Short-Term Debts Nexalin Technology|Quick Ratio nexalin.com
- net income and valuation multiples indicators:
NXL - Final Profit|Expected Profit Nexalin Technology, Inc.|NXL - Price to Earnings Multiple|Future Price to Earnings Nexalin|NXL - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nexalin|NXL - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Nexalin Technology|NXL - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth nexalin.com|NXL - Net earnings per share change in current year|Expected earnings per share growth for next year Nexalin Technology, Inc.
- total revenue and sales volume data:
NXL - Company Total Revenue|Company Future Sales Volume Nexalin Technology|NXL - Market Capitalization-to-Revenue Ratio|Forward P/S Multiple Nexalin Technology|NXL - Annual Revenue Growth (Last Twelve Months)
Summary company analytics:nexalin.com (NXL)
Flagship merchandise of Nexalin Technology, Inc.

Nexalin Technology, Inc. (NXL) TTM earnings per share reflects the monetization of its unique neurostimulation in the fight against resistant disorders. This metric is calculated by dividing the total annual net income by the total number of outstanding shares. By analyzing the TTM earnings per share distribution, an investor can see the actual return on capital. The metric's trend demonstrates the efficiency of clinic scaling, while the upward curve confirms the financial stability of the innovative ecosystem.

Main competitors

acadiahealthcare.com - Net earnings per share (EPS TTM)|Earnings per one share for the last 12 months LFST|BWAY: Net earnings per share (EPS TTM)